Gilead Sciences, Inc. (GILD)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$992M
Holdings value Q1 2024
$72.6B
Value change Q1 2024
-$1.83B
Grand Portfolio weight change Q1 2024
-0.004%
Number of holders
1748
Number of Buys Q1 2024
691
Number of Sells Q1 2024
-840
Average Buys Q1 2024 %
+0.01%
Average Sells Q1 2024 %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 990M $72.5B -$1.92B $73.25 1,639
2023 Q4 1.02B $82.7B +$1.52B $81.01 1,783
2023 Q3 1.02B $76.4B -$84.7M $74.94 1,693
2023 Q2 1.02B $79B +$679M $77.07 1,721
2023 Q1 1.02B $84.3B +$1.11B $82.97 1,759
2022 Q4 1.03B $90.2B +$2.94B $85.85 1,805
2022 Q3 1B $62.5B +$711M $61.69 1,648
2022 Q2 993M $62B +$438M $61.81 1,642
2022 Q1 990M $59.6B -$888M $59.45 1,660
2021 Q4 1.01B $74.7B +$583M $72.61 1,747
2021 Q3 1B $70.6B +$792M $69.85 1,625
2021 Q2 990M $69B +$1.35B $68.86 1,605
2021 Q1 979M $63.8B +$1.42B $64.63 1,619
2020 Q4 970M $57.1B +$270M $58.26 1,622
2020 Q3 975M $62.2B -$551M $63.19 1,602
2020 Q2 989M $76.6B -$321M $76.94 1,689
2020 Q1 1B $74.8B +$628M $74.76 1,717
2019 Q4 1.01B $65.8B +$196M $64.98 1,621
2019 Q3 1.01B $64.2B -$120M $63.38 1,522
2019 Q2 1.02B $70.3B +$2.3B $67.56 1,543
2019 Q1 1.02B $66B +$797M $65.01 1,551
2018 Q4 1.02B $63.7B +$264M $62.55 1,569
2018 Q3 1.02B $78.8B +$2.8B $77.21 1,601
2018 Q2 993M $70.3B -$1.08B $70.84 1,597
2018 Q1 1.02B $77.1B +$639M $75.39 1,644
2017 Q4 1.02B $73.2B +$1.66B $71.64 1,669
2017 Q3 1B $81.4B +$3B $81.02 1,596
2017 Q2 978M $69.2B +$592M $70.78 1,625
2017 Q1 975M $66.2B +$6.06B $67.92 1,620
2016 Q4 992M $71B +$203M $71.61 1,668
2016 Q3 995M $78.6B -$2.25B $79.12 1,657
2016 Q2 1.04B $86.7B -$4.47B $83.42 1,679
2016 Q1 1.1B $98.1B -$5.71B $91.86 1,710
2015 Q4 1.14B $115B -$2.94B $101.19 1,705
2015 Q3 1.16B $114B -$3.14B $98.19 1,640
2015 Q2 1.2B $138B -$3.07B $117.08 1,638
2015 Q1 1.23B $121B -$1.47B $98.13 1,566
2014 Q4 1.26B $119B -$3.55B $94.26 1,522
2014 Q3 1.29B $138B -$9.07B $106.45 1,397
2014 Q2 1.38B $114B -$5.14B $82.91 1,330
2014 Q1 1.45B $116B +$14.6B $70.86 1,266